Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Kern

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Cardiology Research and Practice|June 9, 2025
Fractal Laws for Bifurcation Quantitative Coronary Angiography to Assess Left Main Bifurcation LesionsMattia Lunardi, Nozomi Kotoku, Carlo Briguori, et al.
Journal of Clinical Medicine|January 8, 2023
Clinical Characteristics and Predictors of In-Hospital Mortality of Patients Hospitalized with COVID-19 InfectionLeszek Gromadziński, Maciej Żechowicz, Beata Moczulska, et al.
Science (New York, N.Y.)|September 5, 2020
An ethical framework for global vaccine allocationEzekiel J Emanuel, Govind Persad, Adam Kern, et al.
Cardiology Journal|March 20, 2025
Early treatment with inhibitors of P2Y12 receptor in patients with ST-segment elevation myocardial infarction - 2023 ESC recommendations and scientific evidence. Is clinical evidence sufficient to suggest a move towards precision medicine? The ELECTRA-SIRIO 2 investigators' viewpointJacek Kubica, Piotr Adamski, Jolita Badariene, et al.
International Journal of Cardiology|December 8, 2024
Prolonged antithrombotic treatment after de-escalation of dual antiplatelet therapy in patients after acute coronary syndrome - which strategy should be applied? The ELECTRA-SIRIO 2 investigators standpointJacek Kubica, Piotr Adamski, Małgorzata Ostrowska, et al.
Cardiology Journal|May 22, 2025
Extended dual antithrombotic therapy in patients with chronic coronary syndrome - which agent should be added to aspirin?Jacek Kubica, Piotr Adamski, Katarzyna Buszko, et al.
Cardiology Journal|June 7, 2021
A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical studyJacek Kubica, Piotr Adamski, Piotr Niezgoda, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Cardiology Research and Practice|June 9, 2025
Fractal Laws for Bifurcation Quantitative Coronary Angiography to Assess Left Main Bifurcation LesionsMattia Lunardi, Nozomi Kotoku, Carlo Briguori, et al.
Journal of Clinical Medicine|January 8, 2023
Clinical Characteristics and Predictors of In-Hospital Mortality of Patients Hospitalized with COVID-19 InfectionLeszek Gromadziński, Maciej Żechowicz, Beata Moczulska, et al.
Science (New York, N.Y.)|September 5, 2020
An ethical framework for global vaccine allocationEzekiel J Emanuel, Govind Persad, Adam Kern, et al.
Cardiology Journal|March 20, 2025
Early treatment with inhibitors of P2Y12 receptor in patients with ST-segment elevation myocardial infarction - 2023 ESC recommendations and scientific evidence. Is clinical evidence sufficient to suggest a move towards precision medicine? The ELECTRA-SIRIO 2 investigators' viewpointJacek Kubica, Piotr Adamski, Jolita Badariene, et al.
International Journal of Cardiology|December 8, 2024
Prolonged antithrombotic treatment after de-escalation of dual antiplatelet therapy in patients after acute coronary syndrome - which strategy should be applied? The ELECTRA-SIRIO 2 investigators standpointJacek Kubica, Piotr Adamski, Małgorzata Ostrowska, et al.
Cardiology Journal|May 22, 2025
Extended dual antithrombotic therapy in patients with chronic coronary syndrome - which agent should be added to aspirin?Jacek Kubica, Piotr Adamski, Katarzyna Buszko, et al.
Cardiology Journal|June 7, 2021
A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical studyJacek Kubica, Piotr Adamski, Piotr Niezgoda, et al.
Pageof 7